CCDC13

gene
On this page

Also known as FLJ25467

Summary

CCDC13 (coiled-coil domain containing 13, HGNC:26358) is a protein-coding gene on chromosome 3p22.1, encoding Coiled-coil domain-containing protein 13 (Q8IYE1). Required for primary cilia formation and promotes the localization of the ciliopathy protein BBS4 to both centriolar satellites and cilia.

Acts upstream of or within DNA damage response; cytoplasmic microtubule organization; and non-motile cilium assembly. Located in centriolar satellite.

Source: NCBI Gene 152206 — RefSeq curated summary.

At a glance

  • GWAS associations: 4
  • Clinical variants (ClinVar): 136 total
  • MANE Select transcript: NM_144719

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26358
Approved symbolCCDC13
Namecoiled-coil domain containing 13
Location3p22.1
Locus typegene with protein product
StatusApproved
AliasesFLJ25467
Ensembl geneENSG00000244607
Ensembl biotypeprotein_coding
Entrez152206

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 4 protein_coding_CDS_not_defined, 2 protein_coding, 2 retained_intron

ENST00000310232, ENST00000435327, ENST00000466031, ENST00000472921, ENST00000479576, ENST00000482100, ENST00000492806, ENST00000954780

RefSeq mRNA: 1 — MANE Select: NM_144719 NM_144719

CCDS: CCDS2705

Canonical transcript exons

ENST00000310232 — 16 exons

ExonStartEnd
ENSE000010781994277317642773253
ENSE000013676334270575642709139
ENSE000013720974270968442709798
ENSE000013746534273963442739810
ENSE000013751154274592342746027
ENSE000013770814274289642743057
ENSE000013789104273046742730589
ENSE000013815584273347042733609
ENSE000013896934273570742735913
ENSE000034923364275257542752717
ENSE000034928214275812542758351
ENSE000035172984273288742732970
ENSE000036258474274725742747373
ENSE000036362254275193642752025
ENSE000036651864275706642757214
ENSE000036717914271316242713316

Expression profiles

Bgee: expression breadth ubiquitous, 162 present calls, max score 91.08.

FANTOM5 (CAGE): breadth broad, TPM avg 0.7842 / max 29.3205, expressed in 321 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
418160.7014312
418140.056139
418130.02015
418120.00663

Top tissues by expression

240 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right uterine tubeUBERON:000130291.08gold quality
olfactory segment of nasal mucosaUBERON:000538683.56gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047382.04gold quality
nucleus accumbensUBERON:000188278.09gold quality
caudate nucleusUBERON:000187377.78gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099176.69gold quality
left testisUBERON:000453376.66gold quality
adenohypophysisUBERON:000219676.12gold quality
putamenUBERON:000187475.80gold quality
pituitary glandUBERON:000000775.55gold quality
right testisUBERON:000453475.39gold quality
testisUBERON:000047374.77gold quality
prefrontal cortexUBERON:000045174.74gold quality
monocyteCL:000057674.72gold quality
hypothalamusUBERON:000189874.27gold quality
leukocyteCL:000073873.90gold quality
amygdalaUBERON:000187673.60gold quality
Brodmann (1909) area 9UBERON:001354073.47gold quality
right frontal lobeUBERON:000281073.39gold quality
left lobe of thyroid glandUBERON:000112073.07gold quality
thyroid glandUBERON:000204672.77gold quality
metanephros cortexUBERON:001053372.77gold quality
esophagogastric junction muscularis propriaUBERON:003584172.74gold quality
right lobe of thyroid glandUBERON:000111972.73gold quality
lower esophagus muscularis layerUBERON:003583372.68gold quality
lower esophagusUBERON:001347372.63gold quality
anterior cingulate cortexUBERON:000983572.59gold quality
corpus callosumUBERON:000233672.56gold quality
mucosa of transverse colonUBERON:000499172.54gold quality
forebrainUBERON:000189072.28gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-MTAB-9388yes7.76
E-ANND-3yes7.16

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

23 targeting CCDC13, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-126-5P100.0072.713180
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-453499.9966.581907
HSA-MIR-449299.8768.253611
HSA-MIR-6842-5P99.8067.541587
HSA-MIR-7110-5P99.8067.841712
HSA-MIR-6752-5P99.5967.321243
HSA-MIR-449899.4767.422360
HSA-MIR-318299.4068.152454
HSA-MIR-6882-5P99.3571.131206
HSA-MIR-4685-5P99.2565.991563
HSA-MIR-6837-5P99.2565.471632
HSA-MIR-544B99.1867.411632
HSA-MIR-4650-3P99.0168.391062
HSA-MIR-6829-5P98.8665.121480
HSA-MIR-465698.7966.221306
HSA-MIR-6804-3P98.7264.82852
HSA-MIR-5088-5P97.9764.28487
HSA-MIR-128997.4665.37655
HSA-MIR-6734-5P95.7065.56950
HSA-MIR-3130-3P94.9866.97574
HSA-MIR-371B-3P94.4866.59345

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_rerioccdc13ENSDARG00000063451
mus_musculusCcdc13ENSMUSG00000079235
rattus_norvegicusCcdc13ENSRNOG00000025643
drosophila_melanogasterCG13032FBGN0036652

Protein

Protein identifiers

Coiled-coil domain-containing protein 13Q8IYE1 (reviewed: Q8IYE1)

All UniProt accessions (1): Q8IYE1

UniProt curated annotations — full annotation on UniProt →

Function. Required for primary cilia formation and promotes the localization of the ciliopathy protein BBS4 to both centriolar satellites and cilia.

Subunit / interactions. Interacts with PCM1, CEP290 and PCNT.

Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Centriolar satellite. Cilium basal body.

RefSeq proteins (1): NP_653320* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR038929CCDC13Family

UniProt features (16 total): coiled-coil region 4, region of interest 3, modified residue 3, sequence variant 3, compositionally biased region 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8IYE1-F176.770.50

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (3): 258, 469, 536

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 54 (showing top): GOBP_CYTOPLASMIC_MICROTUBULE_ORGANIZATION, GOCC_MICROTUBULE_ORGANIZING_CENTER, EFC_Q6, GOBP_CILIUM_ORGANIZATION, GOCC_CENTROSOME, GOBP_DNA_DAMAGE_RESPONSE, chr3p22, GOBP_ORGANELLE_ASSEMBLY, GOBP_MICROTUBULE_BUNDLE_FORMATION, GOBP_CELL_PROJECTION_ORGANIZATION, GOBP_AXONEME_ASSEMBLY, GOCC_CYTOPLASMIC_REGION, GOCC_CILIUM, GOCC_CILIARY_BASAL_BODY, GOCC_CENTRIOLAR_SATELLITE

GO Biological Process (4): DNA damage response (GO:0006974), cytoplasmic microtubule organization (GO:0031122), non-motile cilium assembly (GO:1905515), cell projection organization (GO:0030030)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (5): centrosome (GO:0005813), centriolar satellite (GO:0034451), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), cell projection (GO:0042995)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
cellular response to stress1
microtubule cytoskeleton organization1
supramolecular fiber organization1
cilium assembly1
cellular component organization1
binding1
centriole1
microtubule organizing center1
centrosome1
intracellular anatomical structure1
intracellular membraneless organelle1

Protein interactions and networks

STRING

672 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CCDC13KRABD3A5PL33530
CCDC13CEP131Q9UPN4528
CCDC13CCDC14Q49A88515
CCDC13KIAA0753Q2KHM9505
CCDC13PIBF1Q8WXW3497
CCDC13CFAP210Q0VFZ6491
CCDC13CCDC18Q5T9S5489
CCDC13CFAP184Q2M329476
CCDC13CCDC160A6NGH7463
CCDC13CEP126Q9P2H0454
CCDC13CEP72Q9P209453
CCDC13SEL1L3Q68CR1453
CCDC13CCDC12Q8WUD4448
CCDC13CCDC81Q6ZN84445
CCDC13PDE6CP51160444

IntAct

173 interactions, top by confidence:

ABTypeScore
PCM1PCNTpsi-mi:“MI:0914”(association)0.710
PCNTPCM1psi-mi:“MI:0914”(association)0.710
CEP131CEP290psi-mi:“MI:0914”(association)0.650
CCDC13TCHPpsi-mi:“MI:0915”(physical association)0.600
CCDC13CCND3psi-mi:“MI:0915”(physical association)0.560
CCDC13CCHCR1psi-mi:“MI:0915”(physical association)0.560
TP53BP2CCDC13psi-mi:“MI:0915”(physical association)0.560
USP54CCDC13psi-mi:“MI:0915”(physical association)0.560
MEOX2CCDC13psi-mi:“MI:0915”(physical association)0.560
CCDC13TFIP11psi-mi:“MI:0915”(physical association)0.560
CCDC13DISC1psi-mi:“MI:0915”(physical association)0.560
CCDC13ZRANB1psi-mi:“MI:0915”(physical association)0.560
NEFLCCDC13psi-mi:“MI:0915”(physical association)0.560
CDR2CCDC13psi-mi:“MI:0915”(physical association)0.560
MYF5CCDC13psi-mi:“MI:0915”(physical association)0.560
CCDC13psi-mi:“MI:0915”(physical association)0.560
EFHC2CCDC13psi-mi:“MI:0915”(physical association)0.560
CCDC13GMCL1psi-mi:“MI:0915”(physical association)0.560
FCHO1CCDC13psi-mi:“MI:0915”(physical association)0.560
KIAA1328CCDC13psi-mi:“MI:0915”(physical association)0.560
RALBP1CCDC13psi-mi:“MI:0915”(physical association)0.560
TRIM23CCDC13psi-mi:“MI:0915”(physical association)0.560
CCDC13LZTS1psi-mi:“MI:0915”(physical association)0.560
ZBED1CCDC13psi-mi:“MI:0915”(physical association)0.560
CCDC13GOLGA2psi-mi:“MI:0915”(physical association)0.560

BioGRID (53): CCDC13 (Two-hybrid), CCDC13 (Two-hybrid), CCDC13 (Two-hybrid), CCDC13 (Two-hybrid), CCDC13 (Two-hybrid), CCDC13 (Two-hybrid), CCDC13 (Two-hybrid), CCDC13 (Two-hybrid), CCDC13 (Two-hybrid), CCDC13 (Two-hybrid), CCDC13 (Two-hybrid), CCDC13 (Two-hybrid), CCDC13 (Two-hybrid), CCDC13 (Two-hybrid), CCDC13 (Two-hybrid)

ESM2 similar proteins: A0JMQ7, A0JMY4, A2AUM9, A2BDR7, A2BGP7, A6NI79, A6PWD2, A6QNP9, B1AJZ9, D3YV10, G9G127, O35550, O35551, O75330, O94986, P0CB05, Q05D60, Q0VFN8, Q0VFX2, Q15276, Q17QT2, Q3UPP8, Q498G2, Q4KLY0, Q4PJT6, Q4R703, Q4V7B0, Q5JU67, Q5NVN6, Q5U3A8, Q5U3Z6, Q5U4W1, Q5ZL12, Q66KE8, Q6DFC2, Q6DIS8, Q6IMY1, Q6NRC9, Q6P402, Q7M6Y5

Diamond homologs: D3YV10, Q8IYE1

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 54 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Regulation of PLK1 Activity at G2/M Transition524.4×3e-04

GO biological processes:

GO termPartnersFoldFDR
non-motile cilium assembly635.6×6e-06
cilium assembly710.5×4e-04

Disease & clinical

Clinical variants and AI predictions

ClinVar

136 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance107
Likely benign13
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

3320 predictions. Top by Δscore:

VariantEffectΔscore
3:42709653:AC:Adonor_gain1.0000
3:42709654:CC:Cdonor_gain1.0000
3:42709699:T:TAdonor_gain1.0000
3:42713156:CCCTA:Cdonor_loss1.0000
3:42713157:CCTA:Cdonor_loss1.0000
3:42713158:CTAC:Cdonor_loss1.0000
3:42713159:TACCT:Tdonor_loss1.0000
3:42713160:A:Tdonor_loss1.0000
3:42713161:C:CGdonor_loss1.0000
3:42713205:C:Adonor_gain1.0000
3:42734280:A:ACdonor_gain1.0000
3:42734280:AAGT:Adonor_gain1.0000
3:42734281:A:Cdonor_gain1.0000
3:42735700:TAC:Tdonor_loss1.0000
3:42735701:ACT:Adonor_loss1.0000
3:42735702:CTC:Cdonor_loss1.0000
3:42735705:A:ACdonor_gain1.0000
3:42735705:ACG:Adonor_loss1.0000
3:42735705:ACGTG:Adonor_gain1.0000
3:42735706:C:Adonor_loss1.0000
3:42735706:C:CAdonor_gain1.0000
3:42735706:CGTG:Cdonor_gain1.0000
3:42735706:CGTGC:Cdonor_gain1.0000
3:42735923:C:CTacceptor_gain1.0000
3:42735924:A:Tacceptor_gain1.0000
3:42739628:CCATA:Cdonor_loss1.0000
3:42739629:CATAC:Cdonor_loss1.0000
3:42739630:ATACC:Adonor_loss1.0000
3:42739631:TACC:Tdonor_loss1.0000
3:42739632:A:ACdonor_gain1.0000

AlphaMissense

4661 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
3:42739650:A:GL383P0.988
3:42752669:A:GL140P0.985
3:42739734:C:GR355P0.984
3:42739638:A:GL387P0.983
3:42757104:A:GL111P0.983
3:42730506:C:GR560P0.982
3:42757137:A:GL100P0.982
3:42757149:C:GR96P0.982
3:42735780:A:GL433P0.981
3:42745942:A:GI269T0.978
3:42747306:A:GL224P0.978
3:42730497:A:GL563P0.976
3:42735906:A:GL391P0.976
3:42745964:A:GW262R0.976
3:42745964:A:TW262R0.976
3:42757134:A:GL101P0.976
3:42709019:G:CF703L0.974
3:42709019:G:TF703L0.974
3:42709021:A:GF703L0.974
3:42743047:A:GL279P0.974
3:42747273:A:GL235P0.974
3:42735759:C:GR440P0.973
3:42739642:C:GA386P0.972
3:42752654:C:GR145P0.972
3:42747303:C:GR225P0.971
3:42730476:A:GL570P0.970
3:42735897:A:GL394P0.970
3:42745958:C:GG264R0.968
3:42757176:A:GL87P0.967
3:42730500:C:GR562P0.963

dbSNP variants (sampled 300 via entrez): RS1000022688 (3:42713388 C>T), RS1000043507 (3:42770634 A>G,T), RS1000117738 (3:42716757 C>A,T), RS1000127617 (3:42732241 G>A), RS1000191977 (3:42716278 A>G), RS1000365267 (3:42756312 A>G), RS1000375234 (3:42756008 C>G,T), RS1000459528 (3:42730645 C>T), RS1000495342 (3:42731055 G>A), RS1000553105 (3:42749754 GT>G), RS1000555669 (3:42743449 G>C,T), RS1000631058 (3:42774597 A>G), RS1000718982 (3:42726025 A>G), RS1000740998 (3:42737072 C>A), RS1000825785 (3:42736136 A>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

4 associations (top):

StudyTraitp-value
GCST001762_774Obesity-related traits2.000000e-07
GCST001762_789Obesity-related traits2.000000e-07
GCST002129_6Periodontitis (DPAL)6.000000e-06
GCST002595_14Clozapine-induced agranulocytosis3.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0005188CCL11 measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

20 total (human), top 20 by PubMed support.

ChemicalActions (top 5)PubMed papers
entinostatincreases expression, affects cotreatment2
Air Pollutantsincreases expression, affects expression, increases abundance2
Phenylmercuric Acetateaffects cotreatment, increases expression2
Smokedecreases expression, increases abundance, increases expression2
dicrotophosdecreases expression1
bisphenol Aaffects cotreatment, increases methylation1
tris(2-butoxyethyl) phosphateaffects expression1
butyraldehydedecreases expression1
pentanaldecreases expression1
2-palmitoylglycerolincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, increases expression1
abrineincreases expression1
dorsomorphinaffects cotreatment, increases expression1
licochalcone Bincreases expression1
Fulvestrantincreases methylation, affects cotreatment1
Benzo(a)pyreneaffects methylation, decreases methylation, increases methylation1
Ozoneaffects expression, increases abundance1
Phthalic Acidsincreases methylation1
Tobacco Smoke Pollutiondecreases expression1
Okadaic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.